Identification of modulators of the ALT pathway through a native FISH-based optical screen
Cell Reports · 2025
DOI: 10.1016/j.celrep.2024.115114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Reports, 2025. Verfasst von Benura Azeroglu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Telomere Homeostasis, In Situ Hybridization, Fluorescence, Telomere. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 104 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NCI NIH HHS, Intramural NIH HHS, Cancer Prevention and Research Institute of Texas.
Abstract (Originalsprache)
A significant portion of human cancers utilize a recombination-based pathway, alternative lengthening of telomeres (ALT), to extend telomeres. To gain further insights into this pathway, we developed a high-throughput imaging-based screen named TAILS (telomeric ALT in situ localization screen) to identify genes that either promote or inhibit ALT activity. Screening over 1,000 genes implicated in DNA transactions, TAILS reveals both well-established and putative ALT modulators. Here, we present the validation of factors that promote ALT, such as the nucleosome-remodeling factor CHD4 and the chromatin reader SGF29, as well as factors that suppress ALT, including the RNA helicases DExD-box helicase 39A/B (DDX39A/B), the replication factor TIMELESS, and components of the chromatin assembly factor CAF1. Our data indicate that defects in histone deposition significantly contribute to ALT-associated phenotypes. Based on these findings, we demonstrate that pharmacological treatments can be employed to either exacerbate or suppress ALT-associated phenotypes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Genome Integrity, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA.
- Department of Molecular Biosciences, The University of Texas at Austin, Austin, TX 78712, USA; Department of Medicine, Università degli Studi di Udine, 33100 Udine, Italy.
- High-Throughput Imaging Facility, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.
- Radiation Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: travis.stracker@nih.gov.
Förderung
- NCI NIH HHS
- Intramural NIH HHS
- Cancer Prevention and Research Institute of Texas
Zitieren
APA
Azeroglu, B., Khurana, S., Wang, S. C., Tricola, G. M., Sharma, S., Jubelin, C., Cortolezzis, Y., Pegoraro, G., Miller, K. M., Stracker, T. H., & Lazzerini Denchi, E. (2025). Identification of modulators of the ALT pathway through a native FISH-based optical screen. Cell Reports. https://doi.org/10.1016/j.celrep.2024.115114
Vancouver
Azeroglu B, Khurana S, Wang SC, Tricola GM, Sharma S, Jubelin C, et al. Identification of modulators of the ALT pathway through a native FISH-based optical screen. Cell Reports. 2025. doi:10.1016/j.celrep.2024.115114
BibTeX
@article{Azeroglu2025,
author = {Azeroglu, Benura and Khurana, Simran and Wang, Shih-Chun and Tricola, Gianna M and Sharma, Shalu and Jubelin, Camille and Cortolezzis, Ylenia and Pegoraro, Gianluca and Miller, Kyle M and Stracker, Travis H and Lazzerini Denchi, Eros},
title = {Identification of modulators of the ALT pathway through a native FISH-based optical screen},
journal = {Cell Reports},
year = {2025},
doi = {10.1016/j.celrep.2024.115114}
}
EUVIMED